RecruitingNCT07691749
Two psychobiotics added to antidepressants for major depression
About this title
Read the official source — NCT07691749Placebo comparisonAges 18–60Pakistan
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
What will I do during this study?
Participants continue their prescribed antidepressant and are randomly assigned to a psychobiotic capsule or placebo (an inactive comparison treatment) once daily for six weeks. Assessments take place at baseline and weeks three and six, with follow-up visits to monitor symptoms and side effects.
- Listed locations
- LahoreSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 31, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 86
- Sponsor
- Dr Sadia yasir
- Sponsor type
- Individual investigator
- Study type
- Other
- Intervention type
- Dietary supplement, Other
- Locations
- Pakistan
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT07691749
- Official title
Show the full official title
Effect of Psychobiotics (Combined Lactobacillus Helveticus and Bifidobacterium Longus) With Standard Antidepressants in Treatment of Major Depressive Disorder.
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Lahore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Dr Sadia yasir.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
